Clinical Trial Update: A Study to Evaluate Tolerability and Efficacy of Evolocumab (AMG 145) in Japanese Subjects [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating tolerability and efficacy of evolocumab (AMG 145) in Japanese subjects with hypercholesterolemia and high risk for cardiovascula…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Hypercholesterolemia

Drugs mentioned

• Evolocumab (evolocumab)

Snippet

Sponsor: Amgen | Conditions: Hypercholesterolemia and High Risk for Cardiovascular Events | Phase 2 | Status: COMPLETED | Results posted: 2015-10-05